{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:25:38Z","timestamp":1780471538568,"version":"3.54.1"},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,1,26]],"date-time":"2012-01-26T00:00:00Z","timestamp":1327536000000},"content-version":"vor","delay-in-days":25,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2012,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tumour necrosis factor\u2010alpha (TNF\u2010\u03b1) antagonists have advanced the treatment of inflammatory arthropathies, and are even considered for use in refractory sarcoidosis with some success. Paradoxically, cases of new onset sarcoidosis\u2010like diseases are increasingly reported in patients receiving TNF\u2010\u03b1 antagonists. Here, we report three cases of sarcoid\u2010like granulomatosis that developed during treatment with TNF\u2010\u03b1 antagonists. Review of the Biologics clinic data base at Westmead, Sydney, Australia identified three patients whom, during anti\u2010TNF therapy, developed non\u2010caseating granulomas consistent with sarcoidosis. These three cases are described with review of the literature from 2000 to 2009 using PubMed. One hundred and sixty\u2010nine patients within our data base were reviewed for the period 2003\u20132009. Sarcoidosis\u2010like granulomas developed in three patients within a period of 3 to 36\u2003months of treatment with etanercept and\/or adalimumab. All cases demonstrated non\u2010infective, non\u2010caseating granulomas on renal or lymph node biopsy. Improvement was seen in two cases upon cessation of TNF\u2010\u03b1 antagonist and steroid therapy. Interestingly, clinical deterioration was noted upon re\u2010challenge with the same TNF\u2010\u03b1 antagonist in one patient. To date, a total of 37 cases of sarcoid\u2010like granuloma development after anti\u2010TNF therapy have been reported in the literature. Development of sarcoidosis\u2010like granulomatosis in patients treated with TNF\u2010\u03b1 antagonists is a phenomenon previously under\u2010recognised. All three anti\u2010TNF agents have been observed to cause this phenomenon, suggesting a \u2018class effect\u2019 rather than being drug specific.<\/jats:p>","DOI":"10.1111\/j.1445-5994.2011.02612.x","type":"journal-article","created":{"date-parts":[[2011,10,12]],"date-time":"2011-10-12T12:19:59Z","timestamp":1318421999000},"page":"89-94","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["New onset sarcoid\u2010like granulomatosis developing during anti\u2010TNF therapy: an under\u2010recognised complication"],"prefix":"10.1111","volume":"42","author":[{"given":"D.","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Manolios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,1,26]]},"reference":[{"key":"e_1_2_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2005.01.009"},{"key":"e_1_2_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep046"},{"key":"e_1_2_2_4_2","unstructured":"ADRAC.TGA Medicine Summary. 10th March2009."},{"key":"e_1_2_2_5_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.95.3.604"},{"key":"e_1_2_2_6_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.122.5.1858"},{"key":"e_1_2_2_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.3.278"},{"key":"e_1_2_2_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.11154"},{"key":"e_1_2_2_9_2","first-page":"645","article-title":"Sarcoid\u2010related uveitis occurring during etanercept therapy","volume":"21","author":"Hashkes PJ","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_2_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21336"},{"key":"e_1_2_2_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22351"},{"key":"e_1_2_2_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22238"},{"key":"e_1_2_2_13_2","first-page":"648","article-title":"Sarcoid\u2010like granulomatous disease following etanercept treatment for rheumatoid arthritis","volume":"34","author":"Kudrin A","year":"2007","journal-title":"J Rheumatol"},{"key":"e_1_2_2_14_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.27.10.1446"},{"key":"e_1_2_2_15_2","first-page":"99","article-title":"Pulmonary sarcoidosis in a patient with ankylosing spondylitis treated with infliximab","volume":"25","author":"Almod\u00f3var R","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_2_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.078840"},{"key":"e_1_2_2_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-007-0594-1"},{"key":"e_1_2_2_18_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.47.0602"},{"key":"e_1_2_2_19_2","first-page":"2313","article-title":"Neurosarcoidosis in a patient with rheumatoid arthritis during treatment with infliximab","volume":"34","author":"Sturfelt G","year":"2007","journal-title":"J Rheumatol"},{"key":"e_1_2_2_20_2","first-page":"471","article-title":"Sarcoidosis occurring during anti\u2010TNF\u2010\u03b1 treatment for inflammatory rheumatic diseases: report of two cases","volume":"26","author":"Toussirot E","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_2_21_2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080383"},{"key":"e_1_2_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2009.02.003"},{"key":"e_1_2_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2008.11.003"},{"key":"e_1_2_2_24_2","unstructured":"Wyeth Australia Pty Ltd.Product information on enbrel \u00ae etanercept. January2010."},{"key":"e_1_2_2_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra071714"},{"key":"e_1_2_2_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.028498"},{"key":"e_1_2_2_27_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-5-199709010-00003"},{"key":"e_1_2_2_28_2","first-page":"239","article-title":"Sarcoidosis and rheumatoid arthritis","volume":"129","author":"Thompson WR","year":"1966","journal-title":"Ill Med J"},{"key":"e_1_2_2_29_2","first-page":"526","article-title":"Coexistence of rheumatoid arthritis and sarcoidosis: difficulties encountered in the differential diagnosis of common manifestations","volume":"11","author":"Fallahi S","year":"1984","journal-title":"J Rheumatol"},{"key":"e_1_2_2_30_2","first-page":"85","article-title":"A rare case of sarcoidosis with rheumatoid arthritis","volume":"41","author":"Yutani Y","year":"1995","journal-title":"Osaka City Med J"},{"key":"e_1_2_2_31_2","first-page":"381","article-title":"A case of sarcoidosis overlapping with rheumatoid arthritis","volume":"45","author":"Kasumoto H","year":"2003","journal-title":"Nihon Jinzo Gakkai Shi"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1445-5994.2011.02612.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1445-5994.2011.02612.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T05:34:37Z","timestamp":1697348077000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1445-5994.2011.02612.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["10.1111\/j.1445-5994.2011.02612.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1445-5994.2011.02612.x","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"2012-01-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}